Following a pair of similar deals in January and June, Coherus BioSciences has netted itself a hefty chunk of change for the ...

While healthcare was not a major campaign issue in the most recent U.S. election, President-elect Donald Trump, empowered by ...

On the heels of similar deals in the U.S. and the EU, the U.K. is filling up its coffers with doses of bird flu immunizations ...

Exact Sciences has enlisted Lil Jon, the poop emoji and a singing toilet for its latest Cologuard marketing push, remixing ...

Last week, the immuno-oncology specialist revealed that part of the new setup will include CDMO services, as it will produce ...

Over-the-counter drug giant Reckitt shelled out £155 million ($200 million) to expand its manufacturing facility in North Carolina, where it produces the popular cold and flu drug Mucinex.

Robert F. Kennedy Jr.’s appointment last month to lead the U.S. Department of Health and Human Services immediately sent ...

Shortly after a similarly sized venture from Pfizer, French pharma juggernaut Sanofi has unveiled a major manufacturing ...

Unless you have been living under a rock, you’ll know that anti-obesity GLP-1 drugs are the next big thing in pharma, with ...

The FDA notification came seven weeks after the New England Journal of Medicine (NEJM) published a report that seven of 67 ...

Belgium mRNA specialist Quantoom Biosciences and biologics manufacturing specialist Univercells inked a partnership deal with ...

GSK has brought its message about the risks of antimicrobial resistance (AMR) to commuters in London. | GSK has brought its ...